HOUSTON, July 23, 2025 /PRNewswire/ -- Core Laboratories Inc. (NYSE: "CLB") ("Core", "Core Lab", or the "Company") reported second quarter 2025 revenue of ...

HOUSTON, Feb. 4, 2026 /PRNewswire/ -- Core Laboratories Inc. (NYSE: "CLB") ("Core," "Core Lab," or the "Company") reported fourth quarter 2025 revenue of $138,300,000 ...

CEO Lawrence V. Bruno highlighted that "Core continued to execute its strategic plan of technology investments targeted to both solve client problems and capitalize on Core's technical and geographic ...

(1) Three months ended September 30, 2024 includes reversals of stock compensation expense previously recognized due to a change in probability of performance condition for certain executive's share ...

Core Laboratories (NYSE:CLB) reported fourth-quarter and full-year 2025 results that reflected modest top-line growth, continued shareholder returns, and a mix of strength in international demand ...

CEO Lawrence Bruno highlighted that "Core continued to execute its strategic plan of technology investments, targeted to both solve client problems and capitalize on Core's technical and geographic ...

HOUSTON (AP) — HOUSTON (AP) — Core Laboratories Inc. (CLB) on Wednesday reported net income of $7.1 million in its fourth quarter. The Houston-based company said it had profit of 15 cents per share.

Up until last quarter, the greatest headwind facing Core Laboratories (NYSE: CLB) was the steep decline in oil prices, which negatively affected oil-field activities. While the fierceness of that ...

probability of performance condition for certain executive's share awards. (2) Three months ended June 30, 2025 and September 30, 2025 includes the write-down of inventory. (3) Three months ended June ...